Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pastuszak

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Canadian Family Physician Medecin De Famille Canadien|November 7, 1998
Are the new SSRIs safe for pregnant women?N A Kulin, A Pastuszak, G Koren
Lancet (London, England)|October 31, 1997
Safety of first-trimester exposure to topical tretinoin: prospective cohort studyL Shapiro, A Pastuszak, G Curto, et al.
Therapeutic Drug Monitoring|June 1, 1992
Therapeutic drug monitoring of retinoidsJ Klein, D Fernandes, A Pastuszak, et al.
Canadian Family Physician Medecin De Famille Canadien|April 29, 1998
Is topical tretinoin safe during the first trimester?L Shapiro, A Pastuszak, G Curto, et al.
Canadian Family Physician Medecin De Famille Canadien|October 6, 1999
Preconception counseling and women's compliance with folic acid supplementationA Pastuszak, D Bhatia, B Okotore, et al.
Clinics in Dermatology|October 1, 1991
Dermatologic drugs in pregnancyM Bologa, A Pastuszak, N H Shear, et al.
Obstetrics and Gynecology|October 1, 1994
Safety of the new quinolones in pregnancyM Berkovitch, A Pastuszak, M Gazarian, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1996
The safety of astemizole in pregnancyA Pastuszak, B Schick, D D'Alimonte, et al.
Reproductive Toxicology (Elmsford, N.Y.)|January 1, 1992
Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective studyD J Gladstone, M Bologa, C Maguire, et al.
Reproductive Toxicology (Elmsford, N.Y.)|August 26, 1998
Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: a meta-analysisO Fernandes, M Sabharwal, T Smiley, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Canadian Family Physician Medecin De Famille Canadien|November 7, 1998
Are the new SSRIs safe for pregnant women?N A Kulin, A Pastuszak, G Koren
Lancet (London, England)|October 31, 1997
Safety of first-trimester exposure to topical tretinoin: prospective cohort studyL Shapiro, A Pastuszak, G Curto, et al.
Therapeutic Drug Monitoring|June 1, 1992
Therapeutic drug monitoring of retinoidsJ Klein, D Fernandes, A Pastuszak, et al.
Canadian Family Physician Medecin De Famille Canadien|April 29, 1998
Is topical tretinoin safe during the first trimester?L Shapiro, A Pastuszak, G Curto, et al.
Canadian Family Physician Medecin De Famille Canadien|October 6, 1999
Preconception counseling and women's compliance with folic acid supplementationA Pastuszak, D Bhatia, B Okotore, et al.
Clinics in Dermatology|October 1, 1991
Dermatologic drugs in pregnancyM Bologa, A Pastuszak, N H Shear, et al.
Obstetrics and Gynecology|October 1, 1994
Safety of the new quinolones in pregnancyM Berkovitch, A Pastuszak, M Gazarian, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1996
The safety of astemizole in pregnancyA Pastuszak, B Schick, D D'Alimonte, et al.
Reproductive Toxicology (Elmsford, N.Y.)|January 1, 1992
Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective studyD J Gladstone, M Bologa, C Maguire, et al.
Reproductive Toxicology (Elmsford, N.Y.)|August 26, 1998
Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: a meta-analysisO Fernandes, M Sabharwal, T Smiley, et al.
Pageof 4